Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation

被引：2
作者：
Au, W. Y. [1 ]
Fung, A. [1 ]
Lam, K. Y. [1 ]
Lie, A. K. [1 ]
Liang, R. [1 ]
Kwong, Y. L. [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 38卷 / 08期
关键词：
D O I：
10.1038/sj.bmt.1705482
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：573 / 574
页数：2
相关论文
共 6 条
  • [1] Therapy-related myelodysplastic syndrome of recipient origin after allogeneic bone marrow transplantation for acute lymphoblastic leukaemia
    Au, WY
    Lie, AKW
    Ma, SK
    Leung, YH
    Siu, LLP
    Kwong, YL
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (02) : 424 - 426
  • [2] AU WY, 2006, IN PRESS AM J HEMATO
  • [3] CAMPBELL PJ, 2006, BLOOD
  • [4] Elmaagacli AH, 2005, BLOOD, V106, p353A
  • [5] The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients
    Goerttler, PS
    Steimle, C
    März, E
    Johansson, PL
    Andreasson, B
    Griesshammer, M
    Gisslinger, H
    Heimpel, H
    Pahl, HL
    [J]. BLOOD, 2005, 106 (08) : 2862 - 2864
  • [6] Tefferi A, 2005, CELL CYCLE, V4, P1053
1